An evaluation of the association of leukopenia and severe infection in patients with systemic lupus erythematosus

Journal of Clinical Rheumatology

Volumn 19, Issue 3, 2013, Pages 115-120

  Lertchaisataporn, Kamoltip ^a   Kasitanon, Nuntana ^a   Wangkaew, Suparaporn ^a   Pantana, Saowanee ^a   Sukitawut, Waraporn ^a   Louthrenoo, Worawit ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

Leukopenia; Lymphopenia; Neutropenia; Severe infection; SLE

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; ARTICLE; CAUSE OF DEATH; DENGUE; DIARRHEA; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; ENDOCARDITIS; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; INCIDENCE; INFECTION; INFECTION RATE; LEUKOPENIA; LIVER HEMORRHAGE; LUNG HEMORRHAGE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PNEUMONIA; PNEUMOTHORAX; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEPTICEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TRACHEOBRONCHITIS; URINARY TRACT INFECTION;

ADULT; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; INFECTION; LEUKOPENIA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 84876183840     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e318289bb9b     Document Type: Article

References (31)

1. Nossent JC, Swaak AJ. Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus. Q J Med. 1991;80:605-612.
2. Kasitanon N, Louthrenoo W, Sukitawut W, et al. Causes of death and prognostic factors in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol. 2002;20:85-91.
3. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.
4. Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677-2686.
5. Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol. 1992;19:1559-1565.
6. Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum. 1995;38:274-283.
7. Duffy KN, Duffy CM, Gladman DD. Infection and disease activity in systemic lupus erythematosus: a review of hospitalized patients. J Rheumatol. 1991;18:1180-1184.
8. Paton NI, Cheong IK, Kong NC, et al. Risk factors for infection in Malaysian patients with systemic lupus erythematosus. QJM. 1996;89:531-538.
9. Hellmann DB, Petri M, Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore). 1987;66:341-348.
10. Zimmermann B 3rd, Spiegel M, Lally EV. Cryptococcal meningitis in systemic lupus erythematosus. Semin Arthritis Rheum. 1992;22:18-24.
11. Noel V, Lortholary O, Casassus P, et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann Rheum Dis. 2001;60:1141-1144.
12. Gladman DD, Hussain F, Ibanez D, et al. The nature and outcome of infection in systemic lupus erythematosus. Lupus. 2002;11:234-239.
13. Ng WL, Chu CM, Wu AK, et al. Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus. QJM. 2006;99:37-47.
14. Dias AM, do Couto MC, Duarte CC, et al. White blood cell count abnormalities and infections in one-year follow-up of 124 patients with SLE. Ann N Y Acad Sci. 2009;1173:103-107.
15. Lee SW, Park MC, Lee SK, et al. Adjusted neutropenia is associated with early serious infection in systemic lupus erythematosus. Mod Rheumatol. 2012. [Epub ahead of print].
16. de Luis A, Pigrau C, Pahissa A, et al. Infections in 96 cases of systemic lupus erythematosus [in Spanish]. Med Clin (Barc). 1990;94:607-610.
17. Nived O, Sturfelt G, Wollheim F. Systemic lupus erythematosus and infection: a controlled and prospective study including an epidemiological group. Q J Med. 1985;55:271-287.
18. Ginzler E, Diamond H, Kaplan D, et al. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 1978;21:37-44.
19. Uribe AG, Vila LM, McGwin G Jr, et al. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol. 2004;31:1934-1940.
20. Gladman DD, Urowitz MB, Goldsmith CH, et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40:809-813.
21. Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA. 1964;190:104-111.
22. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore). 1971;50:85-95.
23. Michael SR, Vural IL, Bassen FA, et al. The hematologic aspects of disseminated (systemic) lupus erythematosus. Blood. 1951;6:1059-1072.
24. Rivero SJ, Diaz-Jouanen E, Alarcon-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum. 1978;21:295-305.
25. Martinez-Banos D, Crispin JC, Lazo-Langner A, et al. Moderate and severe neutropenia in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2006;45:994-998.
26. Lee P, Urowitz MB, Bookman AA, et al. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med. 1977;46:1-32.
27. Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore). 1989;68:141-150.
28. Lortholary O, Lefort A, Tod M, et al. Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia. Lancet Infect Dis. 2008;8:612-620.
29. Stansell JD, Osmond DH, Charlebois E, et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med. 1997;155:60-66.
30. Moreno S, Baraia-Etxaburu J, Bouza E, et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med. 1993;119:194-198.
31. Pryor BD, Bologna SG, Kahl LE. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum. 1996; 39:1475-1482.